about
Coagulation Factor XIIIA Subunit Missense Mutations Affect Structure and Function at the Various Steps of Factor XIII ActionIdentification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function.Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A2.Clinicohematologic spectrum in patients with lupus anticoagulant.NLRP7 inter-domain interactions: the NACHT-associated domain is the physical mediator for oligomeric assemblyInter-locus as well as intra-locus heterogeneity in LINE-1 promoter methylation in common human cancers suggests selective demethylation pressure at specific CpGs.NLRP7, Involved in Hydatidiform Molar Pregnancy (HYDM1), Interacts with the Transcriptional Repressor ZBTB16.Intron retention resulting from a silent mutation in the VWF gene that structurally influences the 5' splice site.An update of the mutation profile of Factor 13 A and B genes.Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective.The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motif.Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function.An in silico and in vitro approach to elucidate the impact of residues flanking the cleavage scissile bonds of FVIII.Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population.Structural and functional influences of coagulation factor XIII subunit B heterozygous missense mutants.Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces.The nitric oxide synthase 3 gene polymorphisms and their association with deep vein thrombosis in Asian Indian patients.Impact of thrombogenic mutations on clinical phenotypes of von Willebrand disease.Novel insights into structure and function of factor XIIIa-inhibitor tridegin.Prenatal diagnosis of haemophilia A by chorionic villus sampling and cordocentesis: all India Institute of Medical Science experience.Use of Intron 1 and 22 inversions and linkage analysis in carrier detection of hemophilia A in Indians.Homocystine levels, polymorphisms and the risk of ischemic stroke in young Asian Indians.Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease.Prothrombotic polymorphisms, mutations, and their association with pediatric non-cardioembolic stroke in Asian-Indian patients.Recurrent abortions in Asian Indians: no role of factor V Leiden Hong Kong/Cambridge mutation and MTHFR polymorphism.Inherited warfarin resistance in Indian patients: does it occur?Screening of the GPX3 gene identifies the "T" allele of the SNP -861A/T as a risk for ischemic stroke in young Asian Indians.Gene tracking in a family of novel identical twins affected by severe type-III von Willebrand Disease (vWD).Evaluation of role of FV, FVIII and APLAs in the pathogenesis of APCR in FV Leiden negative DVT patients: a study in India.Warfarin and vitamin K compete for binding to Phe55 in human VKOR.Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population.Prevalence of Factor V Genetic Variants Associated With Indian APCR Contributing to Thrombotic Risk.Protein C and Protein S: causative factor for developing a hemorrhagic infarct in a HbE/Beta thalassemia child.Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians.Insights into the Folding of Disulfide-Rich μ-ConotoxinsIn silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepanciesVKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sitesCorrection to: Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population
P50
Q28114772-11848E42-BD8B-4FD9-94AB-BA9062330F93Q30385934-49F2C09D-6286-4B0F-B7D4-3074D4D9DFD2Q30402137-5B7914DF-1658-4D41-95C4-DE6927FE15DAQ33365787-F828AC29-7A35-43FD-9594-2D53CA383A12Q34230280-585C64E4-3BD0-4CAE-910B-275596A38424Q35201085-DF4EDF21-C63A-4B80-AE28-A8481939E16FQ35677533-BB895C7A-994E-4721-A0CA-AE1B8C2DDE79Q37509434-4C9F8033-EBFD-4120-870A-9FED27673FBCQ37884728-B67CE784-55C0-4079-9FD6-F8D87764F83AQ38185863-5711F0CB-779E-4D53-A73E-29FD1A0CA975Q38838336-BF6A8A54-AB6C-4FD7-8601-FE18DD6F38ECQ38981465-C67F46FA-A0DC-473B-BBDB-4FF741BEDBA4Q39181953-8FF30434-FAE6-478E-8187-5CE0C62F9728Q40953510-9EF9826B-B03C-4104-A55A-C50CB7BE6EDBQ41282193-F66B623E-5C2E-4267-B5D3-9A57B5EE82F4Q41866117-7F5996BD-4D8A-4579-B56E-762BDDE2473BQ42443761-4A68452E-14EC-4C58-87C5-A198B2644F7CQ43180177-FCAA81DF-518F-40CE-9C4D-CCA7A734D8E7Q43230371-AE676184-9D86-4DCA-AB78-ECA405B35137Q44573224-E585F6DF-0EB8-4F5C-A5C8-1FFE32CAE618Q45864603-5E8746BC-7532-4B02-BE11-908313D3CE1EQ45886452-673CA552-EEAE-4DE1-8001-1C3536A69034Q46105005-84B90EE9-A6E1-46E6-93B0-723AE37750DFQ46314457-19535601-33D5-474B-9150-228FB02AB994Q46330694-F235E399-6806-4FD2-8667-11C1342E397DQ46832268-CB4B2338-D587-4029-8D61-D7F7F16912D2Q46970476-4CDFA578-E60A-4FEC-9A98-A1F023DA079FQ48602525-50DF397A-B8D9-4F47-9D3E-3E7FB6190787Q48922347-185EDAD0-B993-4EC2-AEA3-B5A24EF44F17Q51210645-AFF3EB6E-C663-4558-AD5A-F3490668ECB0Q51273552-831658E5-7FAF-4C11-8BAE-FEF5CED71F27Q52874413-AD048124-1815-4387-B953-50B1D4A1779EQ53320932-A2BA9B86-DC58-40F6-9C3F-0B4DA64A5920Q53804168-1B4B02E0-F173-4760-978C-85630DFC22DBQ54188927-F14214F0-BB7A-4BCB-91D2-C1954DBE2EBAQ54475683-749579B4-0182-4F74-8FC2-628A435D0F51Q58347193-3DA9B940-58DD-42EC-AF92-338227E7B816Q64039515-F2917212-6699-410C-8BB1-22DD358453CDQ64046002-2DDE86F1-EAAE-460D-89F0-C6AB6874D2A2Q64078524-41BAE753-2E5A-4E78-B170-1C87805657D0
P50
description
researcher (ORCID 0000-0002-4103-5854)
@en
name
Arijit Biswas
@en
Arijit Biswas
@nl
type
label
Arijit Biswas
@en
Arijit Biswas
@nl
prefLabel
Arijit Biswas
@en
Arijit Biswas
@nl
P31
P496
0000-0002-4103-5854